prevalence of hepatitis c, hepatitis b, and hiv infection among hemodialysis patients in jenin district (palestine)

Authors

jq abumwais faculty of allied medical science, jenin university, jenin, palestine

of idris faculty of science and technology, alneelain university, khartoum, sudan

abstract

background and aims: end-stage renal disease patients treated by hemodialysis (hd) are more susceptible for infection by viral hepatitis and human immunodeficiency virus (hiv) infections. infection by these viruses is promoted by the characteristic immunological dysfunction that develops in renal failure and interferes with the patient's ability to eliminate these viruses. prevalence of these viruses among hemodialysis patients in jenin district (palestine) was not studied until now, we aimed in this study to determine the prevalence of hcv, hbv and hiv among hemodialysis patients in jenin district using serological methods, and to define the main risk factors for hcv infection. materials and methods: end-stage renal disease (esrd) patients on maintenance hemodialysis from various demographic areas in jenin district were included in the study. data such as age, sex, drug abuse, history of transplantation were examined. serological markers for hcv, hbv and hiv were determined using a microparticle enzyme immunoassay (meia). pearson’s correlation factor and independent samples t-test were used to analyze the significance of results. results: the patients were 77 (42 males, 35 females, mean age 50.73 ± 16.78 years [age range: 14 – 80 years]), the mean duration of dialysis was 26.97 months with a standard deviation of 35.19 days. the prevalence of hcv was 24.68 % while the prevalence of hbsag and hiv were 0% respectively. hcv seropositivity was associated with longer period of dialysis (p=0.000). there was no statistically significant correlation between age and hcv seropositivity (p=0.630), also there was no statistically significant relationship between sex and infection with hcv (p=0.849). conclusion: the prevalence of hcv among hemodialysis patients in jenin district is high compared to many arab and other countries. none of the patients were a former drug abuser or had a history of tattooing. none of the patients was with a former transplant was hcv positive, so it seemed that the infection was mainly nosocomial during dialysis process. duration of dialysis was an important risk factor (p=0.000). dialysis staff, incomplete disinfection of dialysis machines (monitors), non-isolation of hcv positive patients on special dialysis units or special monitors may be important risk factors. so, careful attention of the preventive infection control measures is essential to limit the transmission of hcv in the dialysis unit in jenin district.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Prevalence of hepatitis C, hepatitis B, and HIV infection among hemodialysis patients in Jenin District (Palestine)

Background and Aims: End-stage renal disease patients treated by hemodialysis (HD) are more susceptible for infection by viral hepatitis and human immunodeficiency virus (HIV) infections. Infection by these viruses is promoted by the characteristic immunological dysfunction that develops in renal failure and interferes with the patient's ability to eliminate these viruses. Prevalence of these v...

full text

Prevalence of hepatitis C, hepatitis B, and HIV infection among hemodialysis patients in Jenin District (Palestine)

Background and Aims: End-stage renal disease patients treated by hemodialysis (HD) are more susceptible for infection by viral hepatitis and human immunodeficiency virus (HIV) infections. Infection by these viruses is promoted by the characteristic immunological dysfunction that develops in renal failure and interferes with the patient's ability to eliminate these viruses. Prevalence of these v...

full text

CHARACTERISTICS AND PREVALENCE OF OCCULT HEPATITIS B VIRUS INFECTION IN PATIENTS WITH HEPATITIS C IN IRAN

 ABSTRACT Background: Hepatitis B virus (HBV) infection in patients who lack detectable hepatitis B surface antigen (HBsAg) is called occult hepatitis B infection. Such infections have been frequently identified in patients with chronic hepatitis Cliver disease, but their prevalence is not known. Methods: 207 patients with chronic hepatitis C who were HCV -RNA and antiHCV positive were stu...

full text

The Absence of Hepatitis C Virus Infection Among Patients with Hepatitis B virus in Mashhad, Iran

Background and Aims: Many studies have provided evidence for the role of hepatitis B and C viruses in the development of liver cancer. Although the routine treatment is available for both conditions, no definite guideline is available to treat patients dually infected with HBV and HCV. This study was performed to determine the frequency of HBV/HCV-coinfection in Mashhad, North-East of Iran. Mat...

full text

Hepatitis B and C prevalence among hemodialysis patients in the West Bank hospitals, Palestine

BACKGROUND Hepatitis B and C virus infection is a lead cause of morbidity and mortality among hemodialysis patients. Yet, little research has focused on the morbidity measures of these serious disorders in low and middle income countries. The study aims to estimate the prevalence of hepatitis B and C among hemodialysis patients in the West Bank hospitals in Palestine. METHODS A retrospective ...

full text

Prevalence of Hepatitis B, C and HIV Infection in Blood Donors in Zanjan, 2005-2006

Background and Objectives: Providing safe blood and prevention of blood-borne infections are among the most important purposes of the Blood Transfusion Organization. The aim of this study was to describe the prevalence of Hepatitis B, C and HIV infection and their determinants in Zanjan blood donors from 2005 to 2006. Material and Methods: In this cross-sectional study, the prevalence of Hepati...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of virology

جلد ۴، شماره ۲، صفحات ۳۸-۴۴

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023